India has conducted 12 million COVID-19 tests, second-highest after US: White House 

More than 3.5 million people have tested positive with the coronavirus and 138,000 died in the US. Globally, more than 13.6 million have tested positive and over 586,000 have died.

Published: 17th July 2020 08:25 AM  |   Last Updated: 17th July 2020 08:42 AM   |  A+A-

Representational Image. (Photo | PTI)


WASHINGTON: After the US, which has carried out a record 42 million COVID-19 tests, India has done the second largest number of 12 million coronavirus tests, the White House has said.

More than 3.5 million people have tested positive with the coronavirus and 138,000 died in the US.

Globally, more than 13.6 million have tested positive and over 586,000 have died.

"With regard to (the coronavirus) testing, we've done more than 42 million tests. The second-highest number is 12 million from India."

"We're leading the world in testing," White House Press Secretary Kayleigh McEnany told reporters at a news conference here on Thursday.

ALSO READ | US reports record 68,428 new coronavirus cases in 24 hours, death toll at 1,38,201: Johns Hopkins

The White House was responding to questions related to the coronavirus pandemic in the US.

"We have done more than any country in the world on testing; there's no doubt about that -- 42 million tests. The country with the next highest number is India at 12 million," McEnany said.

This record testing, she said, is in a very stark contrast than the previous administration.

CBS is reporting that in 2009 under Obama-Biden, the Centers for Disease Control and Prevention abruptly advised states to stop testing for the H1N1 flu and stopped counting individual cases, she said.

Ron Klain, Vice President Biden's former Chief of Staff said this: It is "purely a fortuity that (H1N1) isn't one of the great mass casualty events in American history. It had nothing to do with us doing anything right."

"This is former VP Biden's Chief of Staff. It just had to do with luck," she said.

"Contrary to that, this President led the world in testing; led the world in ventilators -- redistributing ventilators for therapeutics; 13 vaccine candidates -- one going into phase three clinical trial.

"This response has been extraordinary and historic. We didn't pause testing; the Obama-Biden administration did, and that was a shameful decision," McEnany said.

There has been encouraging news on vaccines, the press secretary said.

"Moderna's vaccine candidate is showing promising signs. They produced a positive, neutral immune response among the 45 participants in the study. This is comparable to what we see in recovered patients.

The bottom line is that, so far, we are seeing exactly what you would hope to see in a vaccine.

The Moderna vaccine in particular is expected to reach phase three by late July, with 30,000 participants.

"On the therapeutics front, I just want to note: A very encouraging Regeneron contract. A USD 450 million contract for a monoclonal antibody cocktail. This is a bioengineered version of convalescent plasma, one of the several therapeutics available to treat COVID-19. It can be used for prophylaxis and treatment. They say they could have up to 70 to 300 thousand doses -- by the end of the summer or early fall," she said.

As such there is encouraging news on the therapeutics front, McEnany added.

Stay up to date on all the latest Nation news with The New Indian Express App. Download now


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on are those of the comment writers alone. They do not represent the views or opinions of or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp